Alexander P. Miceli, Ph.D.
Affiliations: | 2012 | Biology & Biomedical Sciences (Molecular Cell Biology) | Washington University, Saint Louis, St. Louis, MO |
Area:
Molecular Biology, Cell BiologyGoogle:
"Alexander Miceli"Parents
Sign in to add mentor| Jason D. Weber | grad student | 2012 | Washington University | |
| (Characterization of the ARF Tumor Suppressor's Checkpoint Response to Hyper-Growth Stimuli.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zolkind P, Przybylski D, Marjanovic N, et al. (2018) Cancer immunogenomic approach to neoantigen discovery in a checkpoint blockade responsive murine model of oral cavity squamous cell carcinoma. Oncotarget. 9: 4109-4119 |
| Griffith OL, Chan SR, Griffith M, et al. (2016) Truncating Prolactin Receptor Mutations Promote Tumor Growth in Murine Estrogen Receptor-Alpha Mammary Carcinomas. Cell Reports. 17: 249-60 |
| Mardis E, Griffith OL, Szeman RC, et al. (2016) Abstract IA20: Genomics of a STAT1 knockout mouse model of human ER+ breast cancer Molecular Cancer Research. 14 |
| Maggi LB, Winkeler CL, Miceli AP, et al. (2014) ARF tumor suppression in the nucleolus. Biochimica Et Biophysica Acta. 1842: 831-9 |
| Miceli AP, Saporita AJ, Weber JD. (2012) Hypergrowth mTORC1 signals translationally activate the ARF tumor suppressor checkpoint. Molecular and Cellular Biology. 32: 348-64 |
| Zhang Y, Forys JT, Miceli AP, et al. (2011) Identification of DHX33 as a mediator of rRNA synthesis and cell growth. Molecular and Cellular Biology. 31: 4676-91 |
| Apicelli AJ, Maggi LB, Hirbe AC, et al. (2008) A non-tumor suppressor role for basal p19ARF in maintaining nucleolar structure and function. Molecular and Cellular Biology. 28: 1068-80 |
| Saab R, Bills JL, Miceli AP, et al. (2006) Pharmacologic inhibition of cyclin-dependent kinase 4/6 activity arrests proliferation in myoblasts and rhabdomyosarcoma-derived cells. Molecular Cancer Therapeutics. 5: 1299-308 |